Monitoring Agency Report for The Quarter ended 30th June 2026

Date: 13th August 2026 Listing Compliance Department BSE Limited, Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 001 Scrip Code: 544482 Scrip Symbol: STARIMAGIN Dear Sir / Ma’am Sub: Monitoring Agency Report for the Quarter ended June 30, 2026 Ref: Regulation 32(6) of the SEBI (Listing Obligations & Disclosures Requirements) Regulations, 2015 With reference to subject matter and pursuant to Regulation 32 (6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulation 41(4) of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith Monitoring Agency Report for the quarter ended June 30, 2026 issued by Infomerics Valuation and Rating Limited, Monitoring Agency, in respect of utilization of proceeds of the IPO of the Company. You are requested to kindly take the same on record Thanking you. For Star Imaging and Path Lab Limited (Formerly Known as Star Imaging and Path Lab Pvt. Ltd) Md Shadab Khan Company Secretary and Compliance Officer Membership Number: A74659 Encl: As above Monitoring Agency Report For Star Imaging and Path lab Limited for the quarter ended June 30, 2026 Monitoring Agency Report Aug 13, 2026 Star Imaging & Path Lab Limited 4B/4, Tilak Nagar Near sant Pura West Delhi – 110018 Dear Sir, Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Initial Public Offer (“IPO”) of Star Imaging and Path lab Limited (“The Company”) We write in our capacity of Monitoring Agency for the Initial Public Offering (IPO) for the amount aggregating to Rs.55.66 crore of the Company and refer to our duties cast under 41 of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended June 30, 2026 as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated July 08, 2025. Request you to kindly take the same on records. Thanking you, For and on behalf of Infomerics Valuation and Rating Limited Manav Mahajan (Senior Director - Ratings) Manav.Mahajan@infomerics.com Report of the Monitoring Agency Name of the Issuer: Star Imaging & Path Lab Limited For quarter ended: June 30, 2026 Name of the Monitoring Agency: Infomerics Valuation and Rating Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Nil Indicate range of percentage deviation from the amount of issue proceeds earmarked for objects. For example, up to 10%, 10 – 25%, 25-50%, 50-75%, 75-100%, not ascertainable etc. * Range of Deviation may be computed by taking weighted average of financial deviation of each object in the ratio of issue proceeds allocated for it. Non-financial deviation may be indicated separately by way of notes. Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The Monitoring Agency (MA) does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit-related analyses. We declare that we do not have any direct / indirect interest in or relationship with the issuer/promoters/directors/management and also confirm that we do not perceive any conflict of interest in such relationship / interest while monitoring and reporting the utilization of issue proceeds by the issuer. We further declare that this report provides true and fair view of the utilization of issue proceeds. Signature: Name of the Authorized Person/Signing Authority: Manav Mahajan Designation of Authorized person/Signing Authority: Senior Director - Ratings Seal of the Monitoring Agency: Date: Aug 13, 2026 1) Issuer Details: Name of the issuer: Star Imaging and Path Lab Limited Names of the promoters of the issuer: Mr. Pawan Gupta, Ms. Chhaya Gupta Industry/sector to which it belongs: The Company is engaged in the Healthcare Sector 2) Issue Details: Issue Period: Aug 08, 2025 – Aug 12, 2025 Type of issue (public/rights): Initial Public Offering (SME) Type of specified securities: Equity Shares Grading: NA Issue size (Rs in Crores): Fresh Issuance of Rs. 55.66 crores (Note No. 1) Note 1 Particulars Amount as per the Prospectus (Rs. In Crores) Total proceeds received from IPO 55.66# Less: Details of expenses incurred related to IPO issue 5.99 Net Proceeds available for utilisation 49.67* #Infomerics Ratings shall be monitoring the Net proceeds. **Net proceeds were revised from Rs 49.07 Crore to Rs 49.67 Crore as the Issue expenses was revised from Rs. 6.58 Crore to Rs. 5.99 Crore The company had offered 48,92,000 Equity Shares under the fresh issue comprising a fresh offer of 39,20,000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 142/- per equity share including a share premium of Rs. 132/- per equity share aggregating up to Rs. 55.66 crore by the company (“fresh offer”) and an offer for sale of 9,72,000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 142/- per equity share including a share premium of Rs. 132/- per equity share (“offered shares”) aggregating up to Rs. 13.80 Crore by Mr. Pawan Gupta (selling shareholder). The issue was fully Subscribed, and the company has allotted same number of Equity Shares to the applicants. 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Particulars Reply Source of information / Comments of Monitoring Comments of certifications considered by Agency Board of Monitoring Agency for Directors preparation of report Whether all the utilization is as per disclosure in Yes, the utilization Chartered Accountant The unutilised proceeds of the No Comment Offer has been made as certificate^, Prospectus, Bank issue stood at Rs.15.13 crore Received Document? per Offer Statements, Management till quarter ended March 31, Document. Undertaking 2026, out of which Rs. 2.62 crore was spent during the quarter ended June 30, 2026 in respect of working capital utilisation. Whether Shareholder approval is obtained in case There are no Not applicable Not applicable No Comment of material deviations from expenditures deviations from the Received expenditures Particulars Reply Source of information / Comments of Monitoring Comments of certifications considered by Agency Board of Monitoring Agency for Directors preparation of report disclosed in Offer disclosed in the Document? Offer Document. Hence no approval is required Whether means of finance for disclosed objects of There is no change Not applicable No No Comment the Issue has changed? in the means of Received finance for disclosed objects Any major deviation observed over the earlier Not applicable Nil No No Comment monitoring agency reports? Received Whether all Government / Statutory approvals Yes Listing approval from BSE No Comments No Comment related to the object(s) obtained? Received Whether all arrangements pertaining to technical Not Applicable Not applicable Not Applicable No Comment assistance/collab [Showing first 8,000 characters — download PDF for full document]